Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1636 | Generic Response Training Control Intervention Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D006963 | Hyperphagia NIH | 0.71 |
| D001068 | Feeding and Eating Disorders NIH | 0.33 |
| D009765 | Obesity NIH | 0.30 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002591 | Polyphagia HPO | 0.71 |
| HP:0001513 | Obesity HPO | 0.30 |
Navigate: Correlations HPO
There is one clinical trial.
This project will test whether a food response training intervention produces lasting body fat loss, use objective brain imaging to examine the mechanism of effect of this treatment and investigate the generalizability of the training to non-training foods, and examine factors that should amplify intervention effects to provide a test of the intervention theory. This novel treatment represents a bottom-up implicit training intervention that does not rely on executive control, prolonged caloric deprivation, and expensive clinicians to deliver, like behavioral weight loss treatments that have not produced lasting weight loss. If this computer-based response training intervention produces sustained body fat loss in overweight individuals, it could be easily implemented very broadly at almost no expense, addressing a leading public health problem.
Description: Change in participant's body fat percentage
Measure: Body Fat Change Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Eating disorder symptoms as measured with the Eating Disorder Diagnostic Interview
Measure: Change in Eating Disorder Symptoms Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Dietary Restraint, Emotional Eating, and External Eating (aggregate score) as measured by the Dutch Eating Behavior Questionnaire
Measure: Dietary Restraint, Emotional Eating, and External Eating Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Chang in Disinhibited Eating as measured by the Three Factor Eating Questionnaire
Measure: Change in Disinhibited Eating Behavior Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Eating When Not Hungry as measured by the Eating in the Absence of Hunger Questionnaire
Measure: Change in Eating in the Absence of Hunger Behavior Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Problematic eating patterns associated with symptoms of addictive behaviors as measured by the Yale Food Addiction Scale
Measure: Change in Food Addiction Behavior Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Physical Activity as measured by the Paffenberger Questionnaire
Measure: Change in Physical Activity Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Substance use frequency (i.e., number of times per day) for alcohol of participants as measured by the Daily Drinking Questionnaire
Measure: Change in Alcohol Use Behavior Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Substance use frequency (i.e., number of times per day) for common recreational drugs of participants as measured by the Daily Drug Taking Questionnaire
Measure: Change in Substance Use Behavior Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Participant behavioral response to food pictures, and subjective palatability rating
Measure: Change in Participant Ratings of Unhealthy Food Palatability Time: Baseline, 1 monthDescription: Change in Participant behavioral response to food pictures, and willingness to pay given dollar amounts (aggregate score) for the pictured food
Measure: Change in Participant Ratings of Food Monetary Value Time: Baseline, 1 monthDescription: Change Participant food craving behaviors as measured by the Food Craving and Liking Scale
Measure: Change in Food Craving and Liking Behavior Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Participant BMI using standard methods of calculation
Measure: Change in Body Mass Index Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in mean R-Peak Amplitude measured using three-lead ECG using PowerLab 8 Diagnostic Suite
Measure: Change in mean R-Peak Amplitude Time: Baseline, 1 month, 3 months, 6 months, 12 monthsDescription: Change in Heart Rate Variability measured using three-lead ECG using PowerLab 8 Diagnostic Suite
Measure: Change in Heart Rate Variability Time: Baseline, 1 month, 3 months, 6 months, 12 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports